mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.06 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.07 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.07 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |